Baluch Khoso
SEC insider (Form 3/4/5 filer). CIK 0001686223. Director at Processa Pharmaceuticals, Inc. (PCSA) and 1 other issuer. 10 reported Form 4/5 transactions since Sep 2024; latest on Jul 26, 2026. Located in VERO BEACH, FL.
Companies Baluch Khoso has filed insider reports for
- Processa Pharmaceuticals, Inc. (PCSA): Director
- Longeveron Inc. (LGVN): Director
Baluch Khoso
CIK: 0001686223
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jul 26, 2026PCSA
Processa Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
33.5K shares- - Mar 31, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect2.3K shares at avg. $2.54$6K - Oct 1, 2025PCSA
Processa Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
100K shares- - Oct 1, 2025PCSA
Processa Pharmaceuticals, Inc.
AwardDirectStock Options (Right to Buy)
300K shares- - Aug 11, 2025LGVN
Longeveron Inc.
PurchaseDirect11.8K shares- - Jul 24, 2025PCSA
Processa Pharmaceuticals, Inc.
AwardDirectRestricted Stock
175.3K shares- - Jul 15, 2025LGVN
Longeveron Inc.
AwardDirect17K shares- - Dec 2, 2024LGVN
Longeveron Inc.
SaleDirect1.3K shares at avg. $2.07$3K - Sep 3, 2024PCSA
Processa Pharmaceuticals, Inc.
AwardDirectRestricted Stock
31.2K shares- - Sep 3, 2024PCSA
Processa Pharmaceuticals, Inc.
AwardDirectRestricted Stock
31.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 26, 2026 |  PCSA Processa Pharmaceuticals, Inc. | Award Restricted Stock Units | 33,500 | - | - | Direct |
| Mar 31, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 2,269 | $2.54 | $5,752 | Direct |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award Restricted Stock Units | 100,000 | - | - | Direct |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award Stock Options (Right to Buy) | 300,000 | - | - | Direct |
| Aug 11, 2025 |  LGVN Longeveron Inc. | Purchase | 11,766 | - | - | Direct |
| Jul 24, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award Restricted Stock | 175,299 | - | - | Direct |
| Jul 15, 2025 | LGVN Longeveron Inc. | Award | 17,000 | - | - | Direct |
| Dec 2, 2024 | LGVN Longeveron Inc. | Sale | 1,250 | $2.07 | $2,588 | Direct |
| Sep 3, 2024 | PCSA Processa Pharmaceuticals, Inc. | Award Restricted Stock | 31,206 | - | - | Direct |
| Sep 3, 2024 | PCSA Processa Pharmaceuticals, Inc. | Award Restricted Stock | 31,206 | - | - | Direct |
1-10 of 10 transactions